APA (7th ed.) Citation

ABA, A., HM, A., AM, A., IM, H., M, A., & GE, B. (2026). Targeting the GSK-3β/mTOR axis: A novel pharmacological strategy for preeclampsia prevention and treatment. Naunyn-Schmiedeberg's archives of pharmacology, 399(9), 12897. https://doi.org/10.1007/s00210-026-05202-2

Chicago Style (17th ed.) Citation

ABA, Alshaikh, Al-Kuraishy HM, Abdelaziz AM, Hepishy IM, Albar M, and Batiha GE. "Targeting the GSK-3β/mTOR Axis: A Novel Pharmacological Strategy for Preeclampsia Prevention and Treatment." Naunyn-Schmiedeberg's Archives of Pharmacology 399, no. 9 (2026): 12897. https://doi.org/10.1007/s00210-026-05202-2.

MLA (9th ed.) Citation

ABA, Alshaikh, et al. "Targeting the GSK-3β/mTOR Axis: A Novel Pharmacological Strategy for Preeclampsia Prevention and Treatment." Naunyn-Schmiedeberg's Archives of Pharmacology, vol. 399, no. 9, 2026, p. 12897, https://doi.org/10.1007/s00210-026-05202-2.